Table 2

Demographic and clinical characteristics of patients with CIS/MS and HLA-DR/DQ typing. RRMS, relapsing remitting MS.

PatientDiseaseSexAgeIgGCSFHLA
IDIndex# of
cells/μl
DRB1*DRB1*DRB3*DRB3*DRB4*DRB4*DRB5*DRB5*DQA1*DQA1*DQB1*DQB1*
Nonresponders
66JORRMSF382.89815:0115:011:011:011:021:026:026:02
103HRCISM370.68915:0115:011:011:011:021:026:026:02
0204AMRRMSF381.04815:0115:011:011:011:021:026:026:02
0247PESPMSF391.5315:017:011:031:011:022:016:023:03
0381MASPMSF450.5315:014:011:011:011:0203:XX6:023:02
0702ANRRMSM450.73515:011:031:011:025:013:016:02
0740RACISF350.534:017:011:011:012:013:012:013:01
0936MARRMSF310.66215:0115:011:011:011:021:026:026:02
0973JORRMSM220.511815:014:021:011:011:023:013:026:02
1125PARRMSM410.6364:0214:542:021:011:013:013:025:03
1292DIRRMSF271.281015:0116:011:012:021:021:025:026:02
1300EVRRMSF370.5723:018:012:024:015:012:014:02
0897URRRMSF341.97715:018:011:011:024:014:026:02
0127ROCISM301.382715:018:011:011:024:014:026:02
1290JASPMSM270.5815:014:041:011:013:026:021:0203:XX
0800THRRMSM220.52715:0111:042:021:011:025:013:016:02
0830OLCISF360.56415:0111:012:021:011:025:013:016:02
0818MARRMSM370.6733:014:071:011:013:015:012:013:01
1206CORRMSF371.37515:014:011:011:011:023:013:026:02
Moderate responders
0780URRRMSM271.19815:019:011:011:011:023:013:036:02
0866JERRMSF301.141011:0113:011:012:021:035:013:016:03
0748URRRMSM531.49715:0115:011:011:011:021:026:026:02
1346JURRMSF211.09127:0113:011:011:011:032:012:016:03
1081SACISF490.71231:018:031:016:013:015:01
0817JDRRMSM280.53615:013:011:011:011:025:012:016:02
High responders
1129RERRMSM320.9237:0111:032:021:032:015:013:013:03
1005MECISF330.76415:033:012:021:011:025:012:016:02
1173DIRRMSM320.51144:0411:042:021:013:015:013:023:01
0718MARRMSF360.54115:013:012:021:015:015:012:013:01
0816DACISF521.141215:0113:012:021:011:031:026:026:03
0776JECISF280.763:018:032:025:016:012:013:01